<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Current Health Articles &#187; Anti Diabetic Rosiglitazone</title>
	<atom:link href="http://www.healthhype.com/tag/anti-diabetic-rosiglitazone/feed" rel="self" type="application/rss+xml" />
	<link>http://www.healthhype.com</link>
	<description>Current Health Care Articles</description>
	<lastBuildDate>Mon, 15 Mar 2010 16:49:50 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Elderly Diabetic Patients are Susceptible to Anti Diabetic Rosiglitazone Increasing Risks of Cardiovascular Problems</title>
		<link>http://www.healthhype.com/elderly-diabetic-patients-are-susceptible-to-anti-diabetic-rosiglitazone-increasing-risks-of-cardiovascular-problems.html</link>
		<comments>http://www.healthhype.com/elderly-diabetic-patients-are-susceptible-to-anti-diabetic-rosiglitazone-increasing-risks-of-cardiovascular-problems.html#comments</comments>
		<pubDate>Sat, 29 Dec 2007 08:35:06 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Current Health Articles]]></category>
		<category><![CDATA[Anti Diabetic Rosiglitazone]]></category>
		<category><![CDATA[Cardiovascular Disease]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[Elderly Diabetes Patients]]></category>

		<guid isPermaLink="false">http://www.healthhype.com/elderly-diabetic-patients-are-susceptible-to-anti-diabetic-rosiglitazone-increasing-risks-of-cardiovascular-problems.html</guid>
		<description><![CDATA[An observational study conducted on the elderly diabetes patients provided sufficient evidence that treatment with the ‘anti diabetic rosiglitazone’ is associated with an increased risk for ‘ischemic cardiovascular events’ as well as heart failure and death.
The research study was conducted at ‘Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada’, by Lorraine Lipscombe and colleagues. Results [...]]]></description>
		<wfw:commentRss>http://www.healthhype.com/elderly-diabetic-patients-are-susceptible-to-anti-diabetic-rosiglitazone-increasing-risks-of-cardiovascular-problems.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
